Medtronic plc (MDT)
Medtronic plc (MDT) from its SEC filings: 2025 revenue $36.4 billion (+8% vs the year before), net margin 0%, free cash flow $5.4 billion. Insider trades, recent filings and a price chart. Free.
| Exchange | NYSE |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Revenue (2025) | $36.4 billion |
| Revenue growth | +8% |
| Net income | $4,801 |
| Net margin | 0.0% |
| Free cash flow | $5.4 billion |
| Diluted EPS | $3.73 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +14% |
| Cash | $1.7 billion |
| Long-term debt | $22.1 billion |
| Share count, 1 year | -0% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-23. Education only, not financial advice.